Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Parry

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|May 7, 2014
Splenic marginal-zone lymphoma: ontogeny and geneticsPanagiotis Baliakas, Jonathan C Strefford, Vasilis Bikos, et al.
The Journal of Biological Chemistry|November 24, 2001
Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogenPeter Simon, F Ulrich Weiss, Miklos Sahin-Toth, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Plos One|December 19, 2013
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphomaMarina Parry, Matthew J J Rose-Zerilli, Jane Gibson, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Molecular Oncology|July 26, 2017
Molecular analysis of single circulating tumour cells following long-term storage of clinical samplesBarbara Mesquita, Dominic G Rothwell, Deborah J Burt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|May 7, 2014
Splenic marginal-zone lymphoma: ontogeny and geneticsPanagiotis Baliakas, Jonathan C Strefford, Vasilis Bikos, et al.
The Journal of Biological Chemistry|November 24, 2001
Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogenPeter Simon, F Ulrich Weiss, Miklos Sahin-Toth, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Plos One|December 19, 2013
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphomaMarina Parry, Matthew J J Rose-Zerilli, Jane Gibson, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Molecular Oncology|July 26, 2017
Molecular analysis of single circulating tumour cells following long-term storage of clinical samplesBarbara Mesquita, Dominic G Rothwell, Deborah J Burt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Pageof 2